Skip to main content

Animations

MJFF Publications

3311 - 3320 of 6433 Results
Title
Year
  • Year
  • 2024
  • 2024
  • 2024
  • 2024
  • 2024
  • 2025
  • 2025
  • 2024
  • 2024
  • 2025
  • Summary Details
    OPEN
    Title: Enhanced detection of distinct honeycomb-structured neuronal SMARCC2 cytobodies in Parkinson’s Disease via Cyclic Heat-Induced Epitope Retrieval (CHIER)
    Journal Name: PLOS ONE
    Publisher: Public Library of Science (PLoS)
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1371/journal.pone.0315183
    Citation Count: 0
  • Summary Details
    OPEN
    Title: TNF-NF-κB-p53 axis restricts in vivo survival of hPSC-derived dopamine neurons
    Journal Name: Cell
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by, cc-by
    DOI - Digital Object Identifier: 10.1016/j.cell.2024.05.030
    Citation Count: 19
  • Summary Details
    OPEN
    Title: Sustained effect of prasinezumab on Parkinson’s disease motor progression in the open-label extension of the PASADENA trial
    Journal Name: Nature Medicine
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/s41591-024-03270-6
    Citation Count: 18
  • Summary Details
    OPEN
    Title: Slovak database of speech affected by neurodegenerative diseases
    Journal Name: Scientific Data
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1038/s41597-024-04171-6
    Citation Count: 1
  • Summary Details
    OPEN
    Title: Bidirectional relationship between olfaction and Parkinson’s disease
    Journal Name: npj Parkinson's Disease
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by, cc-by
    DOI - Digital Object Identifier: 10.1038/s41531-024-00838-4
    Citation Count: 1
  • Summary Details
    OPEN
    Title: LRRK2 -associated parkinsonism with and without in vivo evidence of alpha-synuclein aggregates: longitudinal clinical and biomarker characterization
    Journal Name: Brain Communications
    Publisher: Oxford University Press (OUP)
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1093/braincomms/fcaf103
    Citation Count: 0
  • Summary Details
    OPEN
    Title: History of Traumatic Brain Injury Does Not Influence Rate of Progression of Clinical or Pathological Outcomes in Two Early Parkinson's Disease Cohorts
    Journal Name: European Journal of Neurology
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1111/ene.70090
    Citation Count: 0
  • Summary Details
    OPEN
    Title: Gut Microbial Metabolites and Future Risk of Parkinson's Disease: A Metabolome‐Wide Association Study
    Journal Name: Movement Disorders
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1002/mds.30054
    Citation Count: 3
  • Summary Details
    OPEN
    Title: α‐Synuclein Gene Hypomethylation in LRRK2 Parkinson's Disease Patients
    Journal Name: Movement Disorders
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1002/mds.30094
    Citation Count: 2
  • Summary Details
    OPEN
    Title: Use of Robust Norming to Create a Sensitive Cognitive Summary Score in De Novo Parkinson's Disease: An Illustrative Example
    Journal Name: Movement Disorders
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1002/mds.30111
    Citation Count: 2
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.